Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55279-29-3

Post Buying Request

55279-29-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55279-29-3 Usage

Description

3-Amino-pyridine-4-carbaldehyde is an organic compound with the molecular formula C6H6N2O. It is a derivative of pyridine, featuring an amino group and a formyl group attached to the pyridine ring. 3-AMINO-PYRIDINE-4-CARBALDEHYDE is known for its potential applications in the pharmaceutical and chemical industries due to its unique chemical structure and reactivity.

Uses

Used in Pharmaceutical Industry:
3-Amino-pyridine-4-carbaldehyde is used as a pharmaceutical intermediate for the synthesis of various drugs and drug candidates. Its presence in the molecular structure can contribute to the biological activity and therapeutic effects of the final drug product.
Used in the Synthesis of Hydroxyquinolin-2(1H)-ones:
3-Amino-pyridine-4-carbaldehyde is used in the preparation of hydroxyquinolin-2(1H)-ones and their derivatives. These compounds have potential applications in treating cognitive-related disorders and neuropathic pain disorders. The unique chemical structure of 3-amino-pyridine-4-carbaldehyde allows for the development of novel therapeutic agents that can target specific neurological conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 55279-29-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,2,7 and 9 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 55279-29:
(7*5)+(6*5)+(5*2)+(4*7)+(3*9)+(2*2)+(1*9)=143
143 % 10 = 3
So 55279-29-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H6N2O/c7-6-3-8-2-1-5(6)4-9/h1-4H,7H2

55279-29-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H50024)  3-Aminopyridine-4-carboxaldehyde, 95%   

  • 55279-29-3

  • 250mg

  • 463.0CNY

  • Detail
  • Alfa Aesar

  • (H50024)  3-Aminopyridine-4-carboxaldehyde, 95%   

  • 55279-29-3

  • 1g

  • 1667.0CNY

  • Detail
  • Aldrich

  • (ADE000254)  3-Amino-pyridine-4-carbaldehyde  AldrichCPR

  • 55279-29-3

  • ADE000254-1G

  • 4,512.69CNY

  • Detail

55279-29-3Relevant articles and documents

BICYCLIC HETEROCYCLIC AMIDE DERIVATIVE

-

Paragraph 0221; 0222, (2018/06/04)

The present invention provides a bicyclic heterocyclic amide derivative of formula (1) wherein ring Q1 is optionally-substituted C6-10 aryl group, etc.; R1 and R2 are independently hydrogen atom, etc.; W1 is optionally-substituted C1-4 alkylene group; W2 is -NR3aC(O)-, etc. wherein R3a is hydrogen atom or C1-6 alkyl group; Cy1 is the following group of formula (11), etc.; ring Q2 is optionally-substituted benzene ring, etc.; n and m are indepndently 0, 1 or 2, provided that n and m are not simultaneously 0; X is NR5, etc.; R5 is hydrogen atom, etc.; p is 1, 2, 3, 4 or 5; R4 is, independently when two or more exist, hydrogen atom, etc.; and a pharmacologically acceptable salt thereof, which have a potent inhibitory effect on the sphere-forming ability of cancer cells and are useful as an orally-available anti-tumor agent.

HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF

-

Page/Page column 128, (2011/12/14)

Provided herein are heteroaryl compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use. In one embodiment, the compounds provided herein are useful for the treatment, prevention, and/or management of various disorders, such as CNS disorders and metabolic disorders, including, but not limited to, e.g., neurological disorders, psychosis, schizophrenia, obesity, and diabetes

COMPOUND HAVING TGF-BETA INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

-

Page/Page column 71, (2010/11/24)

The present invention provides compounds of formula (I) or compounds of formula (II) and pharmaceutically acceptable salts or solvates thereof. An objective of the present invention is to provide compounds having TGF2 inhibitory activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55279-29-3